Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1958
Gene Symbol: EGR1
EGR1
0.070 AlteredExpression disease BEFREE β-catenin, present mainly in cytoplasmic and nucleus of gastric cancer cells, was also positively correlated with Egr-1 expression in gastric cancer. 22918686 2013
Entrez Id: 7372
Gene Symbol: UMPS
UMPS
0.320 Biomarker disease CTD_human [Clinical and prognostic significance of protein and gene expression of orotate phosphoribosyltransferase in gastric carcinoma]. 16912530 2006
Entrez Id: 57169
Gene Symbol: ZNFX1
ZNFX1
0.010 Biomarker disease BEFREE ZNFX1 antisense RNA 1 (ZFAS1), a novel lncRNA transcribed in the antisense orientation of zinc finger NFX1-type containing 1(ZNFX1), was found to be increased in multiple cancers, such as gastric cancer and hepatocellular carcinoma, contributing to cancer development and progression. 30288832 2019
Entrez Id: 28954
Gene Symbol: REM1
REM1
0.100 AlteredExpression disease BEFREE ZNF139 expression in GC tissues was significantly higher than that in adjacent normal tissues; ZNF139 expression in GES-1 was very weak, but it expressed in various GC cell lines, with the highest expression in BGC823. 26722429 2015
Entrez Id: 7020
Gene Symbol: TFAP2A
TFAP2A
0.030 Biomarker disease BEFREE Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A. 29610526 2018
Entrez Id: 5358
Gene Symbol: PLS3
PLS3
0.010 Biomarker disease BEFREE Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A. 29610526 2018
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.100 AlteredExpression disease BEFREE XTSJ decoction might inhibit angiogenesis in gastric cancer through IL-8-linked regulation of the VEGF pathway. 27224240 2016
Entrez Id: 7517
Gene Symbol: XRCC3
XRCC3
0.400 GeneticVariation disease BEFREE XRCC1 194Trp was associated with smoking in the CG group, while the variant alleles XRCC1 399Gln and XRCC3 241Met were related with gender, smoking, drinking and H pylori infection in the CG and GC groups. 16425350 2005
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.400 Biomarker disease BEFREE XPO1 inhibition induced cell cycle arrest through p53 activation, but the mechanisms of p53 activation differed among the different types of cancer cells. p53 activation depended on the formation of promyelocytic leukemia (PML) nuclear bodies in gastric cancer and liver cancer cells. 31088931 2019
Entrez Id: 7508
Gene Symbol: XPC
XPC
0.030 GeneticVariation disease BEFREE XPA rs2808668 and drinking, DDB2 rs326222, rs3781619, rs830083 and smoking demonstrated significant interactions in AG; XPC rs2607775 had significant interaction with smoking in GC. 26760766 2016
Entrez Id: 1643
Gene Symbol: DDB2
DDB2
0.010 GeneticVariation disease BEFREE XPA rs2808668 and drinking, DDB2 rs326222, rs3781619, rs830083 and smoking demonstrated significant interactions in AG; XPC rs2607775 had significant interaction with smoking in GC. 26760766 2016
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.400 Biomarker disease BEFREE Xiaotan Sanjie decoction inhibits interleukin-8-induced metastatic potency in gastric cancer. 25663767 2015
Entrez Id: 2068
Gene Symbol: ERCC2
ERCC2
0.400 Biomarker disease CTD_human Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy. 17009404 2006
Entrez Id: 7515
Gene Symbol: XRCC1
XRCC1
0.400 GeneticVariation disease BEFREE X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. 21216841 2011
Entrez Id: 695
Gene Symbol: BTK
BTK
0.010 GeneticVariation disease BEFREE X-linked agammaglobulinemia (XLA) is caused by BTK mutations, patients typically show <2% of peripheral B cells and reduced levels of all immunoglobulins; they suffer from recurrent infections of bacterial origin; however, viral infections, autoimmune-like diseases, and an increased risk of developing gastric cancer are also reported. 26960951 2016
Entrez Id: 407021
Gene Symbol: MIR29A
MIR29A
0.100 Biomarker disease BEFREE Wound healing and Transwell assays revealed that miR-29a-3p suppressed tumor metastasis in GC. 25889078 2015
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 AlteredExpression disease BEFREE WNT8B might play key roles in gastric cancer through activation of the beta-catenin - TCF signaling pathway. 11788899 2002
Entrez Id: 100885779
Gene Symbol: LINC-ROR
LINC-ROR
0.010 AlteredExpression disease BEFREE WNT5A and ROR family receptors, co-expressed in ES cells and gastric cancer, are implicated in the planar cell polarity (PCP) pathway. 16211313 2005
Entrez Id: 1371
Gene Symbol: CPOX
CPOX
0.040 Biomarker disease BEFREE With uni-variate COX analysis, we screened out 37 survival hazardous genes in GC. 29941993 2018
Entrez Id: 9377
Gene Symbol: COX5A
COX5A
0.040 Biomarker disease BEFREE With uni-variate COX analysis, we screened out 37 survival hazardous genes in GC. 29941993 2018
Entrez Id: 1351
Gene Symbol: COX8A
COX8A
0.040 Biomarker disease BEFREE With uni-variate COX analysis, we screened out 37 survival hazardous genes in GC. 29941993 2018
Entrez Id: 84868
Gene Symbol: HAVCR2
HAVCR2
0.050 AlteredExpression disease BEFREE With the T staging of gastric cancer increasing, the expression of Tim-3 gradually increased. 30675200 2019
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.700 Biomarker disease BEFREE With the exception of gastric cancer, there are currently no defined guidelines for HER2 testing in other digestive tumors. 31170116 2019
Entrez Id: 6774
Gene Symbol: STAT3
STAT3
0.400 Biomarker disease BEFREE With multivariate logistical regression analysis, SOCS-3, STAT-3, and the status of extragastric nodal metastasis were identified to be the independent factors of the lymph node metastasis from GC. 23824571 2013
Entrez Id: 1678
Gene Symbol: TIMM8A
TIMM8A
0.100 AlteredExpression disease BEFREE With miR-34a mimic and miR-34a inhibitor transfected into SGC-7901 and SGC-7901/DDP for 48 h, post-transfection changes of miR-34a expression was determined; the effects of miR-34a ectopic expression on the viability of cisplatin-induce gastric cancer cell were assayed by the MTT method. 24068565 2014